AzTrials
AzTrials

Platelets Rich Fibrin, Palatal Donor TissuePhase 4NCT02521467

Adjunctive Role of PRF After Free Gingival Graft Harvesting - Case Series

A Phase 4 study testing Platelets Rich Fibrin in healing of palatal donor tissue in people with Platelets Rich Fibrin, Palatal Donor Tissue, run by Ain Shams University.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Free gingival grafts are important to increase zone of attached gingiva and root coverage. This case series reveals role of platelet-rich fibrin (PRF) as adjunctive therapy in palatal wound healing. The superior healing observed at the PRF membrane sites supports its use in accelerating soft-tissue healing. Read more about this study

Who is it for?
Ages 20 to 45 years
What is being tested?
Platelets Rich Fibrin in healing of palatal donor tissue
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
10 participants
Where
No sites listed yet
Study dates
Jan 2014to Jan 2015
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 45 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Systemic free, Good oral hygiene and insufficient attached gingiva prior to ridge augmentation

Who cannot join

  • High arched palate, medically compromised

About this study

Official title: Adjunctive Role of Platelets Rich Fibrin in Palatal Wound Healing After Free Gingival Graft Harvesting - Case Series

Free gingival grafts are important to increase zone of attached gingiva and root coverage. This case series reveals role of platelet-rich fibrin (PRF) as adjunctive therapy in palatal wound healing. The superior healing observed at the PRF membrane sites supports its use in accelerating soft-tissue healing. PRF membrane as a palatal bandage is an efficacious approach to protect the raw wound area of a palatal donor site to reduce healing time and patient discomfort.

Read the detailed description

Introduction:

Free gingival grafts are one of the common treatment modalities used to increase the zone of keratinized tissue (KT) around implants or prior to ridge augmentation and root coverage. The palatal donor sites had many complications as pain, discomfort and healing by secondary intention. Platelets Rich Fibrin (PRF) is a second generation of platelets concentrate full of growth factors fasten the healing and decrease the pain.

Materials and methods:

Ten patients requiring augmentation of KT participated in this case series. The palatal donor sites of 7 of these patients were covered with PRF membranes with a new suturing technique without palatal stent, the other 3 had palatal stent. Palatal tissue will examined clinically after 3, 7, 10 and 14 days. Considerably very fast healing with 0 pain score was observed during one week in the group with PRF.

Being tested
Platelets Rich Fibrin in healing of palatal donor tissue, Placebo

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Platelets Rich Fibrin in healing of palatal donor tissueBiological

    Platelets Rich Fibrin (PRF) is a second generation of platelets concentrate full of growth factors as PDGF, IGF, TGF which had a role in hemostasis fasten the healing and decrease the pain.

  • PlaceboOther

    Also called Palatal stent

    the other group is a control group, had no biologic in the palatal wound, only palatal stent

Study groups in NCT02521467
Study groupRoleWhat they receive
PRFActive comparatorPlatelets Rich Fibrin
Receives: Biological: Platelets Rich Fibrin in healing of palatal donor tissue
palatal stentPlacebo comparatorPalatal stent
Receives: Other: Placebo

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain Assessment by Visual Analog Scale (VAS)

    VAS ranged from 0 (no pain ) to 10 (severe pain)

    Measured: 1 week postoperative

  2. Clinical healing of the palate

    color match, consistency and thickness of palate (Composite measure)

    Measured: 2 weeks postoperative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Aug 2015 (estimated)
  2. Study startJan 2014
  3. Primary completionJan 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02521467
Sponsor's protocol ID
Doaa Adel
Status last verified
Aug 2015
First submitted
28 Jul 2015
Last updated
13 Aug 2015
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Platelets Rich Fibrin in healing of palatal donor tissue in people with Platelets Rich Fibrin, Palatal Donor Tissue, run by Ain Shams University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Aug 2015. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain Assessment by Visual Analog Scale (VAS) (time frame: 1 week postoperative). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Aug 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in